» Articles » PMID: 30461451

Sarcopenia and Obesity

Overview
Specialty General Medicine
Date 2018 Nov 22
PMID 30461451
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Together with age-related body composition changes, the increased prevalence of obesity observed in the past few decades in older individuals has led to a condition called sarcopenic obesity, characterized by a mismatch between muscle mass and fat mass. The operative definition of sarcopenic obesity is still under discussion and creates difficulties in clinical practice. Muscle weakness, rather than low muscle mass, was previously proposed as an alternative criterion and, more recently, the dynapenic abdominal obese phenotype is of increasing interest because of its unfavorable health consequences and usability in clinical practice.

Recent Findings: This review focuses on the most recent findings of pathogenic inter-relationships between adipose tissue and muscle. Recent studies on health consequences of sarcopenic obesity and dynapenic abdominal obesity are also examined. Despite the lack of consensus on a definition for sarcopenic obesity, progress has been made in the delineation of the treatment principles for this condition.

Summary: Further research is needed to compare different definitions of sarcopenic/dynapenic obesity to clarify the relationship between obesity and the most important adverse outcomes in the elderly. The next step will be the definition of best possible therapeutic approaches for this condition.

Citing Articles

Relationship Between Body Mass Index and Low Skeletal Muscle Mass in Adults Based on NHANES 2011-2018.

Xie R, Li X, Zha F, Li G, Wei-Qiang Zhao , Liang Y Sci Rep. 2025; 15(1):2596.

PMID: 39833326 PMC: 11747499. DOI: 10.1038/s41598-025-87176-4.


Therapeutic potential of in gastrointestinal and hepatic disease.

Duan J, Li Q, Cheng Y, Zhu W, Liu H, Li F MedComm (2020). 2024; 5(12):e70017.

PMID: 39687780 PMC: 11647740. DOI: 10.1002/mco2.70017.


Correlation of insulin resistance-related indicators and obesity-related indicators with sarcopenic obesity and development of diagnostic models: NHANES 1999-2006.

Zhang C, Huang X, Lu H, Chen M, Wang J, Deng H Front Nutr. 2024; 11:1492191.

PMID: 39668900 PMC: 11635994. DOI: 10.3389/fnut.2024.1492191.


Age-Related Changes in Insulin Resistance and Muscle Mass: Clinical Implications in Obese Older Adults.

Rizvi A, Rizzo M Medicina (Kaunas). 2024; 60(10).

PMID: 39459434 PMC: 11509678. DOI: 10.3390/medicina60101648.


Risk Factors of Sarcopenia in COPD Patients: A Meta-Analysis.

Zhou J, Liu Y, Yang F, Jing M, Zhong X, Wang Y Int J Chron Obstruct Pulmon Dis. 2024; 19:1613-1622.

PMID: 39011123 PMC: 11246983. DOI: 10.2147/COPD.S456451.